ArticleNature medicine2022
Modeling global 80-80-80 blood pressure targets and cardiovascular outcomes.
Article in Nature medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
40 citing papers in PubMed, 64 citations in OpenAlex.
- Evaluating implementation of the HEARTS model for management of hypertension and diabetes in Guatemala: protocol for a prospective observational hybrid type 3 study.Implementation science communications · 2026Article
- Integrating a Non-Communicable Disease Care Cascade within Ghana's Community-Based Health Planning and Services (CHPS) Program: the COMBINE Pilot Implementation Trial.medRxiv : the preprint server for health sciences · 2026Article
- Synthetic data Using Population Profiles for cardiOvascular Risk facTors (SUPPORT) in mainland China.Scientific data · 2026Article
- Equity in the continuum of hypertension care: evidence from a nationally representative survey in Nepal.BMC public health · 2026Article
- Observational
- Quality-of-care of Filipino patients with hypertension in primary care settings.BMC primary care · 2026Article
- HEARTS quality: a policy framework to strengthen hypertension and cardiovascular risk management in primary healthcare-insights from HEARTS in the Americas.Lancet regional health. Americas · 2026Review
- Trends in the hypertension care cascade under dual guideline criteria in Peru, 2014-2024: a decade of nationally representative surveys with joinpoint analysis and projections toward the WHO 2030 targets.Frontiers in public health · 2026Article
- Factors associated with medication adherence among hypertensive patients in Namibia.Health SA = SA Gesondheid · 2026Article
- Korea Hypertension Fact Sheet 2025: national trends in hypertension with a special analysis of hypertensive disorders of pregnancy.Clinical hypertension · 2026Article
- [HEARTS quality: a policy framework to strengthen hypertension and cardiovascular risk management in primary healthcare - insights from HEARTS in the AmericasQualidade da iniciativa HEARTS: marco de políticas para fortalecer o manejo da hipertensão e do risco cardiovascular na atenção primária à saúde. Perspectivas da iniciativa HEARTS nas Américas].Revista panamericana de salud publica = Pan American journal of public health · 2026Article
- Association between triglyceride glucose index trajectory and risk of hypertension in rural residents: a prospective cohort study.Scientific reports · 2025Article
- Socioeconomic inequalities and trends in self-reported hypertension and antihypertensive medication use in Australia between 2009 and 2021: a nationwide population-based cohort study.Hypertension research : official journal of the Japanese Society of Hypertension · 2025Article
- Article
- Hypertension research 2024 update and perspectives: blood pressure management.Hypertension research : official journal of the Japanese Society of Hypertension · 2025Review
- Unlocking health equity by eliminating copayments for essential antihypertensive medications.EClinicalMedicine · 2025Review
- Effects of Implemented Residual Stresses on Mechanical Responses and Behavior of the Full-Layered Murine Aortic Medial Ring: A Parametric Finite Element Study.Cardiovascular engineering and technology · 2025Article
- Article
- Ten Recommendations for Accelerating Hypertension and Diabetes Control to Reduce Stroke, Heart, and Renal Disease with the Aim to Save Lives in Cameroon Through Partnerships and Collaborations.Advances in therapy · 2024Review
- Detection of hypertension using a target spectral camera: a prospective clinical study.Scientific reports · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 4 institutions in 3 countries.
Funding
Abstract
As the leading cause of death worldwide, cardiovascular diseases (CVDs) present major challenges for health systems. In this study, we analyzed the effects of better population blood pressure control in the context of a proposed 80-80-80 target: 80% of individuals with hypertension are screened and aware of their diagnosis; 80% of those who are aware are prescribed treatment; and 80% of those on treatment have achieved guideline-specified blood pressure targets. We developed a population CVD model using country-level evidence on CVD rates, blood pressure levels and hypertension intervention coverage. Under realistic implementation conditions, most countries could achieve 80-80-80 targets by 2040, reducing all-cause mortality by 4-7% (76-130 million deaths averted over 2022-2050) and slowing the rise in CVD expected from population growth and aging (110-200 million cases averted). Although populous middle-income countries would account for most of the reduced CVD cases and deaths, low-income countries would experience the largest reductions in disease rates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.